Back to Top Skip to main content

Naval Medical Center Portsmouth's iTClamp wins MHS research award

Image of a plastic clamp on someone's arm The iTClamp, a mechanical wound closure device, is being demonstrated at Naval Medical Center Portsmouth. NMCP’s Combat Trauma Research Group recently won the 2020 Military Health System Research Symposium’s Team Research Award for their redesign of the device, which is superior in treating battlefield wounds, controlling blood loss from potentially lethal hemorrhages, and is faster to employ than traditional methods. (Photo by MC Seaman Ariana Torman.)

Recommended Content:

Research and Innovation | Innovation | Combat Support

Naval Medical Center Portsmouth’s (NMCP) Combat Trauma Research Group (CTRG) recently received the 2020 Military Health System Research Symposium’s Team Research Award for their redesign of a mechanical wound closure device, the iTClamp.

The iTClamp is a mechanical wound closure device that seals wounds versus just putting pressure around the outside of the wound. With the new design, the product works better in junctional areas, parts of the body such as the armpit, neck, and crease of the groin, where it is more difficult to get a wrapping around the wound.

“This idea actually came about by accident,” said Navy Lt. Cmdr. Sean Stuart, NMCP’s medical director of the Emergency Department and director of the CTRG. “Our initial goal was to test the iTClamp and my team and I saw the potential for it to be used in conjunction with hemostatic wound dressing.”

During the testing process, the team had several failures and observed that the design of the device was the cause. The team then decided to publish their research and work on a redesign of the product that would make it more effective. The resulting product was superior in treating battlefield wounds, controlling blood loss from potentially lethal hemorrhages and was faster to employ than traditional methods.

Before winning the award, the CTRG conducted three trials with the first beginning two years ago. The first trial was a research trial that identified areas that needed to be addressed to successfully redesign the device. The second trial was another research trial where the device was tested. The third trial tested not only how the device worked in general, but how it worked in the hands of its intended users, corpsmen. Stuart believes that adding this element to the trial is what set their group apart from others.

“I need to know how my corpsmen can perform with devices and how it will be used on the front lines,” said Stuart. “Is it easy to use? Is it functional? The results from their feedback validated the feasibility of service wide employment of this device.”

The collaborative effort by the members of the CTRG through these three trials resulted in a new, effective, in-field hemorrhage-control technique that will advance the mission of preserving life on the battlefield.

“Hemorrhage control of bleeding is one our biggest problems in military medicine,” said Stuart. “Our motto is ‘saving lives on the battlefield’, and as operational physicians, we have experiences that give us unique insight that backs our research, which others may not have.”

Stuart believes that research is a team effort and a very involved process.

“We have a robust team with a lot of moving parts and that’s why we’ve been able to win this award and do such great things,” said Stuart. “Only through a team approach can you pull off something so complex without missing anything.”

Stuart recognized Dr. Emily Fredrick, the CTRG’s program manager, for keeping all of the parts of the project moving forward.

“It certainly does feel good to have won this award,” said Stuart. “People may not realize the hundreds of hours that goes into developing, designing, and acquiring funds for a study. The group’s purpose is to conduct research that impacts the operational warfighter, so it was rewarding to get that positive feedback and know that something we did is making an impact.”

You also may be interested in...

DHA-PI 3200.01: Research and Development (R&D) Enterprise Activity (EA)

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (p): a. Establishes the Defense Health Agency’s (DHA) procedures for the Deputy Assistant Director (DAD), R&D to manage and execute, on behalf of the Assistant Secretary of Defense for Health Affairs (ASD(HA)), the portion of the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation assigned to it (referred to as the “DHP Science and Technology (S&T) Program)”. The DHP S&T Program includes Budget Activities (BAs) 6.1-6.3 and 6.6. The ASD(HA) provides policy, direction, and guidance to inform planning, programming, budgeting, and execution of the DHP RDT&E appropriation in accordance with statute, regulation, and policy in Reference (a). The DAD-R&D, and Component Acquisition Executive (CAE) manage and execute DHP RDT&E Program funds aligned to them on behalf of the ASD(HA). The CAE is responsible for managing BAs 6.4, 6.5, and 6.7 funding, as well as Procurement and Operations and Maintenance funding required to support DHP-funded Acquisition Programs, regardless of acquisition activity. b. Supports the Director, DHA, in developing appropriate DHA management models to maximize efficiencies in the management and execution of DHP RDT&E-funded activities carried out by the Combatant Commands (CCMDs), Services, Uniformed Services University of the Health Sciences (USU), Defense Agencies, and other DoD Components, as applicable. c. Codifies processes to confirm DHP RDT&E funds are applied towards medical priorities and aligned to ASD(HA) policy, direction, and guidance to develop and deliver innovative medical products and solutions that increase the readiness of the DoD medical mission in accordance with Reference (a). d. Supports the following objectives of the R&D EA: (1) Increasing the quantity, quality, and pace of medical research through improved programmatic organization, processes, and oversight. (2) Ensuring DHP RDT&E funded efforts align to ASD(HA) published program guidance that provides resourcing guidance and translates national, departmental, and Service priorities into specific program objectives. (3) Verifying alignment of DHP RDT&E funds to medical priorities and to ASD(HA) policy, direction, and guidance to ensure the development and delivery of medical materiel and knowledge solutions. (4) Facilitating coordination with the CCMDs, Services, USU, Defense Agencies, and other DoD Components, as applicable, to ensure DHP RDT&E funded activities address joint medical capability gaps, and avoid unnecessary duplication.

Waiver of Restrictive Licensure and Privileging Procedures to Facilitate the Expansion of Telemedicine Services in the Military Health System 12-010

Policy

In order to facilitate the expansion of telemedicine services in the Military Health System, this memorandum waives selective provisions of Department of Defense 602S.13-R, "Clinical Quality Assurance in the Military Health System," June 11 , 2004. This waiver is conditioned on the specific provisions of this memorandum, and shall remain in effect, unless modified or revoked, until the cancellation and reissuance of DoD 602S.13-R, or the issuance of a Department of Defense Instruction for or including telemedicine.

Guidance on the Establishment of a Human Cell, Tissue, and Cellular and Tissue Based Products Program

Policy

This memorandum requests the Services resource a Human Cell, Tissue, and Cellular and Tissue Based Products (HCT/Ps) Program that complies with regulatory standards for management and oversight of HCT/Ps, according to the best fit for their Service.

Planning for the Reform of the Governance of the Military Health System

Policy
  • Identification #: N/A
  • Date: 3/2/2012
  • Type: Guidelines
  • Topics: Innovation
Showing results 1 - 4 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.